{"id":14956,"date":"2019-11-18T17:38:50","date_gmt":"2019-11-18T16:38:50","guid":{"rendered":"https:\/\/www.eurekakit.com\/en\/?p=14956"},"modified":"2025-06-16T10:09:51","modified_gmt":"2025-06-16T08:09:51","slug":"ponatinib-in-plasma-by-lc-ms-ms","status":"publish","type":"post","link":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/","title":{"rendered":"Ponatinib in plasma  BY LC-MS\/MS"},"content":{"rendered":"<table style=\"width: 91.8978%;\" border=\"0\">\n<tbody style=\"text-align: left;\">\n<tr style=\"text-align: left; height: 296px;\">\n<td style=\"text-align: center; height: 296px; width: 22.4584%;\" valign=\"top\"><img decoding=\"async\" class=\" wp-image-90\" style=\"vertical-align: bottom;\" src=\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif\" alt=\"Prodotti\" width=\"283\" height=\"173\" \/><\/td>\n<td style=\"text-align: left; height: 296px; width: 0.924214%;\"><\/td>\n<td style=\"text-align: left; height: 296px; width: 85.0277%;\" valign=\"top\">\n<p style=\"text-align: justify;\">Ponatinib in plasma by\u00a0 LC-MS\/MS \u00a0(<strong><span style=\"color: #0000ff;\">code\u00a0 LC99010<\/span><\/strong>)\u00a0 100 test package.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>INSIGHTS<\/strong><br \/>\nPonatinib (Iclusig\u00ae), has been approved for the treatment of patients with Chronic Myeloid Leukemia (CSF) in the chronic, accelerated or blastic phase, resistant or intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate, or in whom the T315I mutation has been identified. Unfortunately, the clinical use of ponatinib is limited by the possible occurrence of occlusive vascular events (thrombosis and arterial and venous occlusions, including fatal myocardial infarction, stroke, stenosis of the large arterial vessels of the brain, severe peripheral vasculopathy). The Eureka Lab Division diagnostic KIT allows to constantly monitor the plasma concentrations of ponatinib during the therapy of each individual patient. Therefore, it represents for clinicians an important support tool, able to guarantee them the possibility of avoiding excessive plasma exposure to ponatinib that could cause thrombotic events.<\/p>\n<p style=\"text-align: justify;\"><strong><span style=\"text-decoration: underline;\">Principle of the\u00a0 Method:<\/span><\/strong><\/p>\n<p>Ponatinib is analysed by treating the plasma with a suitable deproteinization reagent. The solution is directly injected into LC\/MS.<\/p>\n<table style=\"width: 48.2402%;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 23.6641%; height: 32px; text-align: center;\" valign=\"middle\"><a href=\"https:\/\/www.eurekakit.com\/wp-content\/uploads\/2019\/11\/LC99010-Ponatinib-LCMS-EN-1.pdf\"><img decoding=\"async\" class=\" size-full wp-image-124\" style=\"vertical-align: bottom;\" src=\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2010\/02\/right_blue_arrow.gif\" alt=\"right_blue_arrow\" width=\"32\" height=\"32\" \/><\/a><\/td>\n<td style=\"width: 220.902%;\" valign=\"middle\"><a href=\"https:\/\/www.eurekakit.com\/wp-content\/uploads\/2019\/11\/LC99010-Ponatinib-LCMS-EN-1.pdf\"><strong><span style=\"color: #0000ff;\">IFU<\/span><\/strong><\/a><\/td>\n<\/tr>\n<tr style=\"height: 32px;\">\n<td style=\"width: 23.6641%; height: 32px; text-align: center;\" valign=\"middle\"><a href=\"https:\/\/www.eurekakit.com\/wp-content\/uploads\/2020\/01\/LC05010_ANTIEPILEPTICS_002-1.pdf\"><img decoding=\"async\" class=\" size-full wp-image-124\" style=\"vertical-align: bottom;\" src=\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2010\/02\/right_blue_arrow.gif\" alt=\"right_blue_arrow\" width=\"32\" height=\"32\" \/><\/a><\/td>\n<td style=\"width: 220.902%; height: 32px;\" valign=\"middle\"><a href=\"https:\/\/www.eurekakit.com\/wp-content\/uploads\/2025\/06\/LC99011-FM-1-EN-1.pdf\"><strong><span style=\"color: #0000ff;\">IFU MOBILE\u00a0<\/span><\/strong><strong><span style=\"color: #0000ff;\">PHASE M1<\/span><\/strong><\/a><\/td>\n<\/tr>\n<tr style=\"height: 32px;\">\n<td style=\"width: 23.6641%; height: 32px; text-align: center;\" valign=\"middle\"><a href=\"https:\/\/www.eurekakit.com\/wp-content\/uploads\/2020\/01\/LC05010_ANTIEPILEPTICS_002-1.pdf\"><img decoding=\"async\" class=\" size-full wp-image-124\" style=\"vertical-align: bottom;\" src=\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2010\/02\/right_blue_arrow.gif\" alt=\"right_blue_arrow\" width=\"32\" height=\"32\" \/><\/a><\/td>\n<td style=\"width: 220.902%; height: 32px;\" valign=\"middle\"><a href=\"https:\/\/www.eurekakit.com\/wp-content\/uploads\/2025\/06\/LC99021-FM-2-EN-1.pdf\"><strong><span style=\"color: #0000ff;\">IFU MOBILE\u00a0<\/span><\/strong><strong><span style=\"color: #0000ff;\">PHASE M2<\/span><\/strong><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\">\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"width: 243px; height: 59px;\" border=\"0\">\n<tbody style=\"text-align: left;\">\n<tr style=\"text-align: left;\">\n<td style=\"text-align: left;\"><img decoding=\"async\" class=\" size-full wp-image-92\" title=\"Torna alla pagina precedente\" src=\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/back.png\" alt=\"Torna alla pagina precedente\" width=\"32\" height=\"32\" \/><\/td>\n<td style=\"text-align: left;\"><\/td>\n<td style=\"text-align: left;\"><a href=\"https:\/\/www.eurekakit.com\/en\/farmacologia-clinica-4\/\">back to previous page<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ponatinib in plasma by\u00a0 LC-MS\/MS \u00a0(code\u00a0 LC99010)\u00a0 100 test package. &nbsp; INSIGHTS Ponatinib (Iclusig\u00ae), has been approved for the treatment of patients with Chronic Myeloid Leukemia [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-14956","post","type-post","status-publish","format-standard","hentry","category-non-categorizzato"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ponatinib in plasma BY LC-MS\/MS - Eureka Kit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ponatinib in plasma BY LC-MS\/MS - Eureka Kit\" \/>\n<meta property=\"og:description\" content=\"Ponatinib in plasma by\u00a0 LC-MS\/MS \u00a0(code\u00a0 LC99010)\u00a0 100 test package. &nbsp; INSIGHTS Ponatinib (Iclusig\u00ae), has been approved for the treatment of patients with Chronic Myeloid Leukemia [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/\" \/>\n<meta property=\"og:site_name\" content=\"Eureka Kit\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-18T16:38:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-16T08:09:51+00:00\" \/>\n<meta name=\"author\" content=\"Marketing Eureka\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing Eureka\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/\",\"url\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/\",\"name\":\"Ponatinib in plasma BY LC-MS\/MS - Eureka Kit\",\"isPartOf\":{\"@id\":\"https:\/\/www.eurekakit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif\",\"datePublished\":\"2019-11-18T16:38:50+00:00\",\"dateModified\":\"2025-06-16T08:09:51+00:00\",\"author\":{\"@id\":\"https:\/\/www.eurekakit.com\/#\/schema\/person\/8f4a82edd0f4420cf42f3ade3a2ad455\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#primaryimage\",\"url\":\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif\",\"contentUrl\":\"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.eurekakit.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ponatinib in plasma BY LC-MS\/MS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.eurekakit.com\/#website\",\"url\":\"https:\/\/www.eurekakit.com\/\",\"name\":\"Eureka Kit\",\"description\":\"Eurekakit la pi\u00f9 Ampia Gamma al Mondo di Kit Diagnostici per Strumenti Analitici Cromatografici HPLC, GC, GC-MS e LC-MS\/MS,\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.eurekakit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.eurekakit.com\/#\/schema\/person\/8f4a82edd0f4420cf42f3ade3a2ad455\",\"name\":\"Marketing Eureka\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.eurekakit.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6be14c4c547f773438f0e02d5c3785ef?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6be14c4c547f773438f0e02d5c3785ef?s=96&d=mm&r=g\",\"caption\":\"Marketing Eureka\"},\"sameAs\":[\"http:\/\/www.eurekakit.com\"],\"url\":\"https:\/\/www.eurekakit.com\/en\/author\/marketing-eureka\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ponatinib in plasma BY LC-MS\/MS - Eureka Kit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/","og_locale":"en_US","og_type":"article","og_title":"Ponatinib in plasma BY LC-MS\/MS - Eureka Kit","og_description":"Ponatinib in plasma by\u00a0 LC-MS\/MS \u00a0(code\u00a0 LC99010)\u00a0 100 test package. &nbsp; INSIGHTS Ponatinib (Iclusig\u00ae), has been approved for the treatment of patients with Chronic Myeloid Leukemia [&hellip;]","og_url":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/","og_site_name":"Eureka Kit","article_published_time":"2019-11-18T16:38:50+00:00","article_modified_time":"2025-06-16T08:09:51+00:00","author":"Marketing Eureka","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing Eureka","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/","url":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/","name":"Ponatinib in plasma BY LC-MS\/MS - Eureka Kit","isPartOf":{"@id":"https:\/\/www.eurekakit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#primaryimage"},"image":{"@id":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#primaryimage"},"thumbnailUrl":"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif","datePublished":"2019-11-18T16:38:50+00:00","dateModified":"2025-06-16T08:09:51+00:00","author":{"@id":"https:\/\/www.eurekakit.com\/#\/schema\/person\/8f4a82edd0f4420cf42f3ade3a2ad455"},"breadcrumb":{"@id":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#primaryimage","url":"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif","contentUrl":"http:\/\/www.eurekakit.com\/wp-content\/uploads\/2006\/10\/prodotti.gif"},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurekakit.com\/en\/ponatinib-in-plasma-by-lc-ms-ms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurekakit.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ponatinib in plasma BY LC-MS\/MS"}]},{"@type":"WebSite","@id":"https:\/\/www.eurekakit.com\/#website","url":"https:\/\/www.eurekakit.com\/","name":"Eureka Kit","description":"Eurekakit la pi\u00f9 Ampia Gamma al Mondo di Kit Diagnostici per Strumenti Analitici Cromatografici HPLC, GC, GC-MS e LC-MS\/MS,","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurekakit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.eurekakit.com\/#\/schema\/person\/8f4a82edd0f4420cf42f3ade3a2ad455","name":"Marketing Eureka","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.eurekakit.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6be14c4c547f773438f0e02d5c3785ef?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6be14c4c547f773438f0e02d5c3785ef?s=96&d=mm&r=g","caption":"Marketing Eureka"},"sameAs":["http:\/\/www.eurekakit.com"],"url":"https:\/\/www.eurekakit.com\/en\/author\/marketing-eureka\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/posts\/14956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/comments?post=14956"}],"version-history":[{"count":5,"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/posts\/14956\/revisions"}],"predecessor-version":[{"id":25235,"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/posts\/14956\/revisions\/25235"}],"wp:attachment":[{"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/media?parent=14956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/categories?post=14956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurekakit.com\/en\/wp-json\/wp\/v2\/tags?post=14956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}